Healthcare Services

One of the Major Drivers of the Custom Compounded Therapy Market Is the Growing Demand For Personalized Medications Driving The Growth Of The Market Due To The Need For Tailored Treatments Based On Individual Patient Characteristics

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Custom Compounded Therapy Market By 2030 Starting From Its 2026 Size?

The custom compounded therapy market size has seen robust growth in recent years. It is projected to expand from $5.96 billion in 2025 to $6.42 billion in 2026, advancing at a compound annual growth rate (CAGR) of 7.7%. The market’s historic period growth was primarily driven by factors such as the increasing prevalence of chronic diseases, unmet needs within standardized drug therapies, the expansion of specialty pharmacy services, the growing demand from the geriatric population, and a rising physician preference for customized treatments.

The custom compounded therapy market size is projected to experience substantial growth over the next few years. It is expected to expand to $8.56 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.5%. The expansion during the forecast period is primarily driven by factors such as the increasing embrace of precision medicine approaches, a rising demand for allergen-free formulations, the development of home-based care models, enhanced regulatory clarity for compounding practices, and a growing focus on patient-centric healthcare delivery. Furthermore, significant trends anticipated in this period include the wider adoption of personalized medication formulations, an increasing demand for patient-specific dosage customization, the proliferation of specialty compounding pharmacies, the rising integration of advanced compounding technologies, and a heightened emphasis on ensuring treatment adherence.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28186&type=smp

Which Market Drivers Are Supporting The Expansion Of The Custom Compounded Therapy Market?

The increasing need for individualized medications is anticipated to boost the expansion of the custom compounded therapy market in the future. Personalized medication involves adapting medical treatments to suit a patient’s unique characteristics, requirements, and preferences, frequently drawing on genetic, clinical, and lifestyle data. The uptake of personalized medication is increasing because it can enhance treatment efficacy and minimize negative drug responses by matching therapies to distinct patient profiles. Custom compounded therapy contributes to personalizing medicines through the development of customized formulations that cater to each patient’s specific needs, such as particular dosages, combinations, and methods of delivery, thereby ensuring more potent treatment and better results. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the U.S. food and drug administration gave its approval to 16 novel personalized treatments for individuals suffering from rare diseases, marking a considerable rise from the six approved in 2022. Consequently, the escalating demand for personalized medications is propelling the expansion of the custom compounded therapy market.

Which Segment Categories Define The Custom Compounded Therapy Market?

The custom compounded therapy market covered in this report is segmented –

1) By Product Type: Hormone Replacement Therapy, Pain Management, Dermatology, Nutritional Supplements, Other Product Types

2) By Therapy Type: Intravenous (IV) Therapy, Topical Therapy, Oral Therapy, Subcutaneous Therapy

3) By Formulation: Injectable Formulation, Oral Formulation, Transdermal Formulation

4) By Therapeutic Applications: Oncology, Neurology, Cardiology, Endocrinology, Pain Management

5) By End-User: Hospitals, Clinics, Homecare Settings, Specialty Pharmacies

Subsegments:

1) By Hormone Replacement Therapy: Estrogen Therapy, Testosterone Therapy, Progesterone Therapy, Thyroid Hormone Therapy, Combination Hormone Therapy

2) By Pain Management: Analgesics, Anti-Inflammatory Compounds, Muscle Relaxants, Topical Pain Relief, Opioid-Based Compounds

3) By Dermatology: Anti-Acne Formulations, Anti-Fungal Treatments, Anti-Aging Creams, Topical Steroids, Moisturizers And Emollients

4) By Nutritional Supplements: Vitamins, Minerals, Amino Acids, Probiotics, Herbal Supplements

5) By Other Product Types: Veterinary Compounds, Pediatric Formulations, Allergen-Free Medications, Specialty Compounds

Which Trends Are Shaping The Future Of The Custom Compounded Therapy Market?

Leading companies in the custom compounded therapy market are prioritizing the development of innovative solutions, such as advanced compounding software, to address the increasing demand for tailored, precise, and efficient medication preparation. This compounding software streamlines the formulation process by integrating digital automation, quality control mechanisms, and real-time data tracking, providing a more reliable and scalable alternative to traditional manual compounding methods. For example, in October 2025, CurifyLabs, a health-technology company based in Finland, unveiled its Next-Generation Compounding Software, an advanced platform designed to boost accuracy and efficiency in personalized medicine. This system supports automated formulation design, integrates with smart compounding devices, and incorporates built-in quality safeguards to reduce human error. It allows pharmacies and healthcare facilities to consistently produce customized therapies, enhance traceability through digital documentation, and accelerate preparation times. By delivering a fully digital compounding workflow, this solution significantly enhances the capabilities of custom compounded therapy and supports safer, more individualized patient care.

Who Are The Top Companies Competing In The Custom Compounded Therapy Market?

Major companies operating in the custom compounded therapy market are Hikma Pharmaceuticals PLC, Fagron N.V., Nephron Pharmaceuticals Corporation, Belmar Pharmacy LLC, Empower Clinic Services LLC, Medisca Pharmaceutique Inc., Central Admixture Pharmacy Services Inc., Wedgewood Connect LLC, AnazaoHealth Corporation, Wells Pharmacy Network LLC, Institutional Pharmacy Solutions Inc., Bennett Pharmaceuticals of America LLC, Bravado Pharmaceuticals LLC, Pencol Compounding Pharmacy Inc., Rx3 Compounding Pharmacy Inc., CareFirst Specialty Pharmacy LLC, Vertisis Custom Pharmacy LLC, FarmaKeio Pharmacy Network LLC, Professional Compounding Centers of America, Letco Medical LLC

Read the full custom compounded therapy market report here:

https://www.thebusinessresearchcompany.com/report/custom-compounded-therapy-global-market-report

How Is The Custom Compounded Therapy Market Distributed Across Key Geographic Regions?

North America was the largest region in the custom compounded therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the custom compounded therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Custom Compounded Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28186&type=smp

Browse Through More Reports Similar to the Global Custom Compounded Therapy Market 2026, By The Business Research Company

Crypto Wallet Global Market Report

https://www.thebusinessresearchcompany.com/report/crypto-wallet-global-market-report

Cephalosporin Global Market Report

https://www.thebusinessresearchcompany.com/report/cephalosporin-global-market-report

Nontuberculous Mycobacterial Infection Global Market Report

https://www.thebusinessresearchcompany.com/report/nontuberculous-mycobacterial-infection-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795